6533b7d4fe1ef96bd126294d
RESEARCH PRODUCT
Breast Cancer Organoids Model Patient-Specific Response to Drug Treatment
Cristina BottinAlessandro ZanniniAlessandro ZanniniStefan SchoeftnerStefan SchoeftnerDeborah BonazzaMarina BortulValeria CancilaMariangela SantorsolaMariangela SantorsolaFabrizio ZanconatiGiannino Del SalGiannino Del SalElena CampanerElena CampanerClaudio Tripodosubject
0301 basic medicineCancer ResearchMechanotransductionBreast cancer; Dasatinib; Drug testing; Heterogeneity; Mechanotransduction; Patient‐derived tumor organoids; Statin; YAPPatient‐derived tumor organoidCellDasatinibDrug resistanceSettore MED/08 - Anatomia PatologicaBiologylcsh:RC254-282Article03 medical and health sciencesBreast cancer0302 clinical medicineBreast cancerbreast cancermedicineOrganoidSettore MED/05 - Patologia Clinicadasatinibdrug testingmechanotransductionpatient-derived tumor organoidsGenetic heterogeneitystatinStatinDrug testingBreast cancerDasatinib Drug testing Drug testing Heterogeneity Patient‐derived tumor organoids Statin YAPmedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensIn vitroDasatinib030104 developmental biologymedicine.anatomical_structureOncologyCell culture030220 oncology & carcinogenesisCancer researchPatient‐derived tumor organoidsYAPHeterogeneityheterogeneitymedicine.drugdescription
Tumor organoids are tridimensional cell culture systems that are generated in vitro from surgically resected patients&rsquo
year | journal | country | edition | language |
---|---|---|---|---|
2020-12-01 | Cancers |